This invention relates to the use of potent potassium channel blockers or
a formulation thereof in the treatment of glaucoma and other conditions
related to elevated intraoccular pressure in the eye of a patient. This
invention also relates to the use of such compounds to provide a
neuroprotective effect to the eye of a mammalian species, particularly
humans.